EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TNFAIP9 protects against the development of the early stage of chronic kidney disease: Focus on inflammation and fibrosis

Ying Chen, Yanqiu Li, Deyu Zhang iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0325334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Ying Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Inflammation. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor alpha-induced protein 9 (TNFAIP9) is a crucial effector molecule that protects cells from inflammatory and metabolic damage. This study focuses on investigating the role and regulatory mechanisms of TNFAIP9 in the progression of chronic kidney disease (CKD). By analyzing CKD-related datasets from the GEO database, we discovered that TNFAIP9 was upregulated in CKD patients and CKD mice compared to their normal controls. To elucidate the functional role of TNFAIP9, we established a mouse model of CKD through a two-step 5/6 nephrectomy (Nx). The experimental mice were transduced with an adenoviral vector to express TNFAIP9. The results showed that mice undergoing 5/6-Nx developed evident renal impairment, inflammation, and fibrosis. Overexpression of TNFAIP9 resulted in the remission of renal impairment, a decreased inflammatory response, and a reduced expression of fibrotic markers. In vitro, human renal tubular epithelial human kidney-2 (HK-2) cells were exposed to tumor necrosis factor-alpha (TNF-α) or transforming growth factor-beta (TGF-β) to simulate inflammatory and fibrotic conditions, respectively. Then, the overexpression plasmid or small interfering RNA (siRNA) targeting TNFAIP9 was transfected into HK-2 cells to either overexpress or knock down the target protein. Overexpression of TNFAIP9 reduced the TNF-α-induced inflammatory response, while its knockdown amplified it. Likewise, overexpression of TNFAIP9 decreased the TGF-β-induced fibrosis, whereas its knockdown heightened it. In summary, it is suggested that TNFAIP9 plays a protective role against the early stage of CKD by suppressing renal inflammation and fibrosis. Therefore, targeting TNFAIP9 could be a promising therapeutic approach for CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicInflammationAnimalsHumansFibrosisMiceMaleDisease Models, AnimalCell LineTumor Necrosis Factor-alphaMice, Inbred C57BLTransforming Growth Factor betaKidney

Substanzen

Tumor Necrosis Factor-alphaTransforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

ORCID-Profile: Deyu Zhang

Förderung

  • Postdoctoral Science Foundation of China

Zitieren

APA

Chen, Y., Li, Y., & Zhang, D. (2025). TNFAIP9 protects against the development of the early stage of chronic kidney disease: Focus on inflammation and fibrosis. PLOS One. https://doi.org/10.1371/journal.pone.0325334

Vancouver

Chen Y, Li Y, Zhang D. TNFAIP9 protects against the development of the early stage of chronic kidney disease: Focus on inflammation and fibrosis. PLOS One. 2025. doi:10.1371/journal.pone.0325334

BibTeX
@article{Chen2025,
  author = {Chen, Ying and Li, Yanqiu and Zhang, Deyu},
  title = {TNFAIP9 protects against the development of the early stage of chronic kidney disease: Focus on inflammation and fibrosis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325334}
}
Kostenlos starten →